« Previous
Next »
Journal of the American Academy of Dermatology
Volume 60, Issue 5
, Pages 786-791
, May 2009
Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment
References
- . Connective tissue diseases. In: Elder D, Elenitsas R, Jaworsky C, Johnson B editor. Lever's histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven Publishers; 1997;p. 253–285
- . Twenty year incidence survey of systemic sclerosis. Arthritis Rheum. 1988;31:57
- . The connective tissue diseases. In: Champion RH, Burton JL, Ebling FJG editor. Textbook of dermatology. Vol 3. Oxford: Blackwell Scientific Publications; 1992;p. 2225–2266
- . Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70:1068–1076
- . Scleroderma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF editor. Dermatology in general medicine. 4th ed. New York: McGraw-Hill Book Company; 1993;p. 2156–2167
- . Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology. 2003;207:298–301
- . The connective tissue diseases. In: Champion RH, Burton JL, Ebling FJG editor. Textbook of dermatology. Vol 3. Oxford: Blackwell Scientific Publications; 1992;p. 2163–2194
- High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol. 1997;36:938–944
- Low-dose UVA1 phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998;38:21–26
- . Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum. 1990;33:1256–1263
- Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol. 2000;43:1017–1023
- . Skin collagen content in progressive systemic sclerosis (scleroderma) and localized scleroderma. Arthritis Rheum. 1979;22:130–140
- . Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol. 1994;103:359–363
- . PUVA therapy in disabling pansclerotic morphea of children. Br J Dermatol. 1995;132:830–831
- . Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed. 2000;16:43–49
- . UVA therapy for scleroderma. J Am Acad Dermatol. 1999;40:787–788
- . A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54:440–447
- . Objective assessment of photoageing effects using high-frequency ultrasound in PUVA-treated psoriasis patients. Br J Dermatol. 2002;147:291–298
- . Ultrasound imaging of psoriatic skin: a noninvasive technique to evaluate treatment of psoriasis. Int J Dermatol. 1994;33:786–790
- UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res. 1991;283:506–511
- . Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol. 1992;99:440–444
- Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed. 2001;17:149–155
- UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed. 2006;22:247–253
- Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis: a clinico-pathologic study. Photodermatol Photoimmunol Photomed. 2004;20:148–156
Funding sources: None.
Conflicts of interest: None declared.
PII: S0190-9622(08)02496-1
doi: 10.1016/j.jaad.2008.12.013
© 2008 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Journal of the American Academy of Dermatology
Volume 60, Issue 5
, Pages 786-791
, May 2009
